Drug recall · May 15, 2019
Ketorolac Tromethamine Injection recall
Why: Lack of Sterility Assurance: Microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the products.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ketorolac Tromethamine Injection, USP, 60 mg per 2 mL (30 mg per mL), 2 mL Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, NDC: 25021-701-02
- Lots / codes
Lot #: M813513, Exp. Feb 2020
- Quantity
- 75,825 vials
- Company
- Sagent Pharmaceuticals Inc, Schaumburg, IL
- Distribution
- Nationwide USA and Puerto Rico
- Initiated
- April 30, 2019 · Voluntary: Firm initiated
- Classified
- May 9, 2019
- Reported
- May 15, 2019
- Ended
- September 28, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ketorolac
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.